SEC Form 4 · accession 0001209191-17-011320
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason Cole
Officer — Chief Legal Officer
Period of report
Feb 14, 2017
Accepted (ET)
Feb 16, 2017 · 8:15 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 14, 2017 | S | 3,772 | $80.0128 | D | 12,717 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2016.
- F2The range in prices for the transaction reported on this line was $80.00 to $80.15. The average weighted price was $80.0128. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.